£1
1 period on recordActive15405578Private limited companyManchester
NABAMA LIMITED
Significant control: Mohammad Farid Khan (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Nabama Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Nabama Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
NABAMA LIMITED is an active private limited company (company number 15405578) incorporated on 11 January 2024, registered in Manchester. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest dormant accounts cover the period ending 31 January 2025, showing net assets of £1.
Peer position · net assets
By net assets it sits in the lower half of 138 comparable companies in Manchester (median £436, upper quartile £124k).
02
Ownership and control
- Dr. Mohammad Farid Khan
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 11 January 20242 yrs ago
- Next accounts due
- 31 October 2026in 3 days
- Confirmation statement due
- 25 January 2027in 89 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Dormant
- Size band
- MicroCompanies Act thresholds
05
Financials
Not reported
Not reported
Not reported
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 January 2025 | £1 | — | — | — | — | — | — |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets above zeroNet assets £1 at 31 January 2025
- Incorporated two to five years agoIncorporated 11 January 2024
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 89 days
- Next accounts duein 3 days
- Accounts period endNet assets £1 · dormant accounts
- Incorporated
08
Similar companies in Manchester
- DOMINION BIOTECH LTDAlderley Edge · inc. Jan 2024
- BIOMARKER TECHNOLOGIES (BMKGENE) UK LTDMacclesfield · inc. Jan 2024
- LIR THERAPEUTICS LIMITEDAltrincham · inc. Jan 2024
- INTEGRATED BIOLOGIX LTDWarrington · inc. Jan 2024
- MOLECULAR GLUE LABS LTDAltrincham · inc. Feb 2024
- IMMUNOKEY LTDWilmslow · inc. Feb 2024
All companies incorporated on 11 January 2024 · in Jan 2024.
09
Reminders for NABAMA LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.